Skip to main content
. Author manuscript; available in PMC: 2022 Sep 11.
Published in final edited form as: Nat Med. 2022 Jun;28(6):1116–1120. doi: 10.1038/s41591-022-01801-7

Figure 1. Research priorities for novel technologies with forcibly displaced populations.

Figure 1.

Forcibly displaced populations can greatly benefit from case-control studies with omics and digital tools to identify potential omics biomarkers and digital phenotypes associated with disease. Omics biomarkers and digital phenotypes can then be employed in cohort studies to evaluate their validity as screening tools for diseases among these populations. Randomized control trials (RCTs) can evaluate the effectiveness of omics or digital-based interventions in preventing or managing diseases that are prevalent in these communities.